🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
61.36
-0.63 (-1.02%)
At close: Nov 19, 2026, 4:00 PM EST
60.14
-1.22 (-1.99%)
After-hours: Nov 19, 2026, 4:44 PM EST

Eton Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
55.6325.9414.9421.3916.3114.41
Cash & Short-Term Investments
55.6325.9414.9421.3916.3114.41
Cash Growth
49.86%73.69%-30.17%31.17%13.18%-32.35%
Receivables
26.4311.765.363.411.855.47
Inventory
11.0815.4215.230.910.560.55
Prepaid Expenses
3.657.465.491.131.293.18
Total Current Assets
96.7860.5841.0226.842023.6
Property, Plant & Equipment
1.40.640.210.150.260.22
Other Intangible Assets
44.2830.8834.884.744.753.62
Other Long-Term Assets
0.060.020.010.010.010.02
Total Assets
157.2792.1176.1231.7425.0327.47

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
16.510.984.171.851.771.77
Accrued Expenses
20.0115.9415.78.963.661.37
Current Portion of Long-Term Debt
11.848.79-5.381.031.42
Current Portion of Leases
0.250.070.080.05--
Current Unearned Revenue
0.50.46----
Other Current Liabilities
3.372.26----
Total Current Liabilities
54.138.4919.9516.246.464.56
Long-Term Debt
11.2321.7729.81-5.385.26
Long-Term Leases
1.020.460.110.020.110.02
Long-Term Unearned Revenue
1.421.76----
Other Long-Term Liabilities
2.63.481.83---
Total Liabilities
70.3565.9651.716.2611.959.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.030.030.030.030.030.03
Additional Paid-In Capital
151.01138.62132.29119.52116.19111.72
Retained Earnings
-64.11-112.49-107.89-104.07-103.13-94.11
Total Common Equity
86.9226.1524.4315.4813.0817.63
Shareholders' Equity
86.9226.1524.4315.4813.0817.63
Total Liabilities & Equity
157.2792.1176.1231.7425.0327.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
24.3331.0829.995.466.526.7
Net Cash (Debt)
31.29-5.14-15.0615.939.787.71
Net Cash Growth
401.19%--62.90%26.85%-45.52%
Net Cash Per Share
1.00-0.19-0.580.620.390.31
Filing Date Shares Outstanding
28.8427.2826.8225.6925.4624.63
Total Common Shares Outstanding
28.8327.0526.7125.6925.3524.63
Working Capital
42.6922.0921.0710.613.5419.05
Book Value Per Share
3.020.970.910.600.520.72
Tangible Book Value
42.64-4.72-10.4510.748.3214.01
Tangible Book Value Per Share
1.48-0.17-0.390.420.330.57
Machinery
0.250.520.380.350.340.4
Construction In Progress
----0.01-
Leasehold Improvements
0.230.30.10.10.070.07
SEC Filings: 10-K · 10-Q